Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Mendel, Carl"'
Autor:
Tweed, Conor D *, Dawson, Rodney, Burger, Divan A, Conradie, Almari, Crook, Angela M, Mendel, Carl M, Conradie, Francesca, Diacon, Andreas H, Ntinginya, Nyanda E, Everitt, Daniel E, Haraka, Frederick, Li, Mengchun, van Niekerk, Christo H, Okwera, Alphonse, Rassool, Mohammed S, Reither, Klaus, Sebe, Modulakgotla A, Staples, Suzanne, Variava, Ebrahim, Spigelman, Melvin
Publikováno v:
In The Lancet Respiratory Medicine December 2019 7(12):1048-1058
Autor:
Dawson, Rodney, Diacon, Andreas H, Everitt, Daniel, van Niekerk, Christo, Donald, Peter R, Burger, Divan A, Schall, Robert, Spigelman, Melvin, Conradie, Almari, Eisenach, Kathleen, Venter, Amour, Ive, Prudence, Page-Shipp, Liesl, Variava, Ebrahim, Reither, Klaus, Ntinginya, Nyanda E, Pym, Alexander, von Groote-Bidlingmaier, Florian, Mendel, Carl M
Publikováno v:
In The Lancet 2-8 May 2015 385(9979):1738-1747
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
Autor:
Francesca Conradie, G Wills, M. Olugbosi, A Calatroni, Mendel Carl M, Pauline Howell, Daniel Everitt, E Sun, N Ngubane, Aliasgar Esmail, A. del Parigi, Angela M. Crook, Melvin Spigelman, Andreas H. Diacon, Olatunde Olayanju, Keertan Dheda, Suzette Oelofse
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 25:453-460
BACKGROUND: There are no data comparing the 6–9 month oral three-drug Nix regimen (bedaquiline, pretomanid and linezolid [BPaL]) to conventional regimens containing bedaquiline (B, BDQ) and linezolid (L, LZD).METHODS: Six-month post end-of-treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b69c6545cf6978d971d8b9d51716e47
https://doi.org/10.5588/ijtld.21.0035
https://doi.org/10.5588/ijtld.21.0035
Autor:
G Wills, Andrew J. Nunn, J. Caoili, Mookho Malahleha, Francis Apolinary Mhimbira, Issa Sabi, Muge Cevik, Cheryl Louw, Anna Bateson, Ahmad Izuanuddin Ismail, M. C. Betteridge, Mendel Carl M, Ebrahim Variava, Daniel Everitt, Vincent Balanag, Suzanne Staples, Ronelle Moodliar, Umesh G. Lalloo, L. Lombard, Stephen H. Gillespie, Richard E. Chaisson, Robert D Hunt, Angela M. Crook, Videlis Nduba, Modulakgotla Sebe, Conor D. Tweed, Susan Swindells, Melvin Spigelman, A. Y.L. Ban, Evans Amukoye, C. H. van Niekerk, Andreas H. Diacon, Stella M. Fabiane, A. del Parigi, Rodney Dawson, R. A. P. Selepe, Francesca Conradie, Timothy D. McHugh, William Brumskine
Publikováno v:
The International Journal of Tuberculosis and Lung Disease
STAND was sponsored by TB Alliance with support from the UK Department for International Development, UK Department of Health (London, UK), Bill and Melinda Gates Foundation (Seattle, WA, USA), US Agency for International Development (Washington DC,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23754b0fb1db6916b0fbc5f98df336b9
https://hdl.handle.net/10023/21773
https://hdl.handle.net/10023/21773
Autor:
Vishak Subramoney, Jerry R Nedelman, David H Salinger, Mengchun Li, Mel Spigelman, Rob Woolson, Daniel Everitt, Mendel Carl M, Karen Wade
Publikováno v:
Antimicrobial Agents and Chemotherapy
Pretomanid was approved by the U.S. FDA, via the limited population pathway for antibacterial and antifungal drugs, as part of a three-drug regimen with bedaquiline and linezolid for the treatment of extensively drug-resistant and treatment-intoleran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74dbafb8a3a94dab3539b14888a1535
https://doi.org/10.1128/aac.01121-20
https://doi.org/10.1128/aac.01121-20
Autor:
Jerry R Nedelman, Naadira Vanker, Divan Aristo Burger, Andreas H. Diacon, Rodney Dawson, Daniel Everitt, Kim Narunsky, Veronique R. de Jager, Frances Pappas, Mendel Carl M
Publikováno v:
Antimicrobial Agents and Chemotherapy. 64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23429204fbad3d90e25622893f56360c
https://doi.org/10.1128/aac.00709-20
https://doi.org/10.1128/aac.00709-20
Autor:
Divan Aristo Burger, Rodney Dawson, Mendel Carl M, Veronique R. de Jager, Kim Narunsky, Frances Pappas, Naadira Vanker, Jerry R Nedelman, Daniel Everitt, Andreas H. Diacon
Publikováno v:
Antimicrobial Agents and Chemotherapy
Linezolid is increasingly used for the treatment of tuberculosis resistant to first-line agents, but the most effective dosing strategy is yet unknown. From November 2014 to November 2016, we randomized 114 drug-sensitive treatment-naive pulmonary tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c1d5a3618f440f8c25a47d1f50cefd
http://europepmc.org/articles/PMC7179319
http://europepmc.org/articles/PMC7179319
Autor:
Tweed, Conor D., Crook, Angela M., Amukoye, Evans I., Dawson, Rodney, Diacon, Andreas H., Hanekom, Madeline, McHugh, Timothy D., Mendel, Carl M., Meredith, Sarah K., Murphy, Michael E., Murthy, Saraswathi E., Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha P., Spigelman, Melvin, Wills, Genevieve H., Gillespie, Stephen H.
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
BMC infectious diseases, vol 18, iss 1
BMC Infectious Diseases
BMC infectious diseases, vol 18, iss 1
BMC Infectious Diseases
Supported by the Global Alliance for TB Drug Development with support from the Bill and Melinda Gates Foundation, the European and Developing Countries Clinical Trials Partnership (grant IP.2007.32011.011), U.S. Agency for International Development,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dbcac10a08875ec4ab3385f4e652464b
http://link.springer.com/article/10.1186/s12879-018-3230-6
http://link.springer.com/article/10.1186/s12879-018-3230-6
Autor:
G Wills, Sara Murthy, Sarah Meredith, Rodney Dawson, Angela M. Crook, Mendel Carl M, Patrick P. J. Phillips, Conor D. Tweed, Stephen H. Gillespie, Andreas H. Diacon, Lerato Mohapi, Cheryl Louw, Melvin Spigelman, Kasha P. Singh, Michael E. P. Murphy, Andrew J. Nunn, Timothy D. McHugh, SR Murray
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
BMC Medicine
BMC medicine, vol 16, iss 1
BMC Medicine
BMC medicine, vol 16, iss 1
This work was supported by the Global Alliance for TB Drug Development with support from the Bill and Melinda Gates Foundation, the European and Developing Countries Clinical Trials Partnership (grant IP.2007.32011.011), the US Agency for Internation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2027adef789965c98ed3fc7ecd254630
http://link.springer.com/article/10.1186/s12916-018-1033-7
http://link.springer.com/article/10.1186/s12916-018-1033-7